树突状细胞疫苗联合抗抗体治疗小鼠肝癌的实验(3)
[3] 吴圣,邵婧怡,王芳,等. PD-L1和PD-1在胃癌组织中的表达及其临床意义[J].安徽医科大学学报,2015,(06):821-825.
[4] HERBST R. S, BAAS, P, KIM D. W, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial [J]. The Lancet, 2016,387():1540-1550.
[5] 冯钟煦,刘剑勇,赵荫农,等. H22细胞全细胞抗原负载的树突状细胞激活肿瘤浸润性淋巴细胞抗小鼠肝癌的实验[J].肿瘤防治研究,2012,(10):1179-1182.
[6] 韦思明,颜志中,周剑. 树突状细胞疫苗联合抗CD137抗体治疗肾细胞癌的实验研究[J].浙江医学教育,2012,(04):47-50.
[7] 马薇,罗殿中,陈源,等. PD-L1和PD-1在非小细胞肺癌中的表达及其临床意义[J].实用医学杂志,2011,(09):1551-1554.
[8] DRAUBE A, KLEIN-GONZáLEZ N, Mattheus S, et al. Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysisc [J]. PLoS One, 2011,6(4):e.
[9] GE Y, XI H, JU S, et al. Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice [J]. Cancer Letters, 336(2), 253-259.
文章来源:《中国肿瘤生物治疗杂志》 网址: http://www.zgzlswzlzz.cn/qikandaodu/2021/0223/501.html